این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Biotechnology، جلد ۲۲، شماره ۴، صفحات ۶۴-۷۷

عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله

عنوان انگلیسی Bioinformatic Approaches for the Identification of Novel Tumor Suppressor Genes and Cancer Pathways in Renal Clear Cell Carcinoma
چکیده انگلیسی مقاله Background: Clear cell renal cell carcinoma (ccRCC, KIRC) is the most prevalent subtype of RCC, and even with different available therapies, the average progression-free survival is worse. Therefore, the identification of new molecular targets could be helpful for its therapeutic purposes.

Materials and Methods: We used the Cancer Genome Atlas to perform bioinformatic analyses for genes with possible tumor suppressor roles in KIRC.

Objective: This research aims to identify new prognostic biomarkers and potential therapeutic targets for this type of cancer.

Results: We identified 14 down-regulated genes in KIRC that had not previously been studied or poorly studied, with the majority of them impacted by increased promoter methylation. Eight genes showed shorter overall survival and worse prognosis, indicating their function as tumor suppressors, and six genes revealed good prognosis. From the 8 genes, C7ORF41 and CTXN3 revealed only downregulation in most cancers, proposing them as highly potential tumor suppressors. Among these 8 genes, the function of CTXN3 in cancers is unknown. Moreover, we identified the CWH43 gene as the major signature of KIRC. In addition, we found different genes as signatures of KIRC tumor stages and grades.

Conclusions: Our results may shed light on identifying KIRC pathogenesis and developing effective therapeutic targets for renal cancers, mainly KIRC
کلیدواژه‌های انگلیسی مقاله tumor suppressor,renal clear cell carcinoma,The Cancer Genome Atlas (TCGA),methylation,Prognostic biomarkers

نویسندگان مقاله Hassan Dastsooz |
Department of Life Sciences and Systems Biology, University of Turin, Turin, Italy

Elham Mohammadisoleimani |
Department of Medical Genetics, Fasa University of Medical Sciences, Fasa, Iran

Hamed Haghi-Aminjan |
Pharmaceutical Sciences Research Center, Ardabil University of Medical Sciences, Ardabil, Iran

Zahra Firoozi |
Department of Medical Genetics, Fasa University of Medical Sciences, Fasa, Iran

Yaser Mansoori |
Department of Medical Genetics, Fasa University of Medical Sciences, Fasa, Iran


نشانی اینترنتی https://www.ijbiotech.com/article_211271_138c4bc98372fb11cee78d80e55389f3.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات